← Leaderboards
Christopher J. Halbrook
University Of Michigan At Ann Arbor
$1,899,655
Attributed
$1,899,655
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $445.3K · FY2018–25$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,899,655 · 4
By mechanism
R37$881,750 · 1
R00$777,639 · 1
K99$122,890 · 1
F32$117,376 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Marina Pasca Di Magliano$14,782,555
- Diane M Simeone$15,596,624
- Costas Andreas Lyssiotis$8,196,905
- Timothy Louis Frankel$4,183,486
- Martin Philbert$6,712,530
Others in their field
Other Emerging Leaders on “Signal Transduction”
- Yunda Huang · Fred Hutchinson Cancer Center$53,064,276
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Leonard Freedman · Leidos Biomedical Research, Inc.$32,575,497
- Bala Raja · Luminostics, Inc.$28,624,460
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
Research focus
Signal TransductionSolid NeoplasmPhysiologySignal PathwayMyeloid CellsPancreatic NeoplasmImmuneMediatingMalignant NeoplasmsResearch ProposalsMetabolicMetabolismPancreatic Ductal AdenocarcinomaOrganoidsEffective TherapyAutomobile DrivingImmunosuppressionMalignant Neoplasm Of PancreasCoculture TechniquesCellsGeneticCancer CellMacrophageTumor
Grant awards (9)
Targeting Metabolic Crosstalk in Pancreatic Cancer$445,319
R37 · FY2025 · CA · contact PI
Targeting Metabolic Crosstalk in Pancreatic Cancer$436,431
R37 · FY2024 · CA · contact PI
Disrupting macrophage metabolism to reduce immunosuppression and enhance therapy in pancreatic cancer$246,369
R00 · FY2022 · CA · contact PI
Disrupting macrophage metabolism to reduce immunosuppression and enhance therapy in pancreatic cancer$81,338
R00 · FY2022 · CA · contact PI
Disrupting macrophage metabolism to reduce immunosuppression and enhance therapy in pancreatic cancer$200,933
R00 · FY2021 · CA · contact PI
Disrupting macrophage metabolism to reduce immunosuppression and enhance therapy in pancreatic cancer$248,999
R00 · FY2020 · CA · contact PI
Disrupting macrophage metabolism to reduce immunosuppression and enhance therapy in pancreatic cancer$122,890
K99 · FY2020 · CA · contact PI
Targeting Epithelial-Immune Cell Crosstalk to Improve Therapy in Pancreatic Cancer$58,338
F32 · FY2019 · CA · contact PI
Targeting Epithelial-Immune Cell Crosstalk to Improve Therapy in Pancreatic Cancer$59,038
F32 · FY2018 · CA · contact PI